Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Ana Isabel Heiniger"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Rafael Parra, Marta Martorell, Maria Eva Mingot-Castellano, Ramiro Núñez, Ana Isabel Heiniger Mazo
Publikováno v:
Blood. 128:3780-3780
INTRODUCTION Current guidelines recommend that subjects with severe hemophilia A (HA) receive prophylaxis in order to prevent severe bleeding and recurrent hemarthrosis that lead to the development of arthropathy, an extremely painful and disabling c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cbf754e840ed246de4ed13c1b01d95ee
https://doi.org/10.1182/blood.v128.22.3780.3780
https://doi.org/10.1182/blood.v128.22.3780.3780
Autor:
Miguel Ángel Sánchez-Chaparro, María Inmaculada Alonso-Calderón, M.J. Ariza-Corbo, Ana Isabel Heiniger-Mazo, Pedro Valdivielso, María Eva Mingot-Castellano, Álvaro Amo Vázquez de la Torre
Publikováno v:
Blood. 124:5053-5053
INTRODUCTION: We have little information about if there is a particular bleeding phenotype of severe haemophilia A female carriers. In the literature, an increased bleeding tendency is described in this group, justified even by levels of factor VIII
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::96e251ccad2008a164c413b25c8bd619
https://doi.org/10.1182/blood.v124.21.5053.5053
https://doi.org/10.1182/blood.v124.21.5053.5053
Autor:
Ana Isabel Heiniger-Mazo, Rocio Tamayo-Bermejo, Dana Diaz-Canales, Maria Eva Mingot-Castellano
Publikováno v:
Blood. 124:1502-1502
BACKGROUND: Replacement therapy with factor VIII (FVIII) in patients with severe hemophilia A has a high cost. To optimize this consumption without an increase in bleeding events or a delay in the recovery of these bleeds is a question of great inter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bdf4102793b2bffe9c90b659fb1bbaef
https://doi.org/10.1182/blood.v124.21.1502.1502
https://doi.org/10.1182/blood.v124.21.1502.1502
Autor:
Ana Isabel Heiniger Mazo, Manuel Espeso de Haro, Maria Cristina Moragues Martinez, Kati Hurst, Manuel Barrios Garcia
Publikováno v:
Blood. 124:5459-5459
BACKGROUND: Primary mediastinal B-cell lymphoma (PMBCL) are a subtype of diffuse large B cell lymphoma (DLBCL), that represent 2-4% of all non-Hodgkin lymphoma (NHL) and 6-12% of DLBCL. They affect young adults with a median age at diagnosis of 35 ye
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f8e19305122baaaab9a41d5c973caf6f
https://doi.org/10.1182/blood.v124.21.5459.5459
https://doi.org/10.1182/blood.v124.21.5459.5459
Autor:
Josefina Perez-Nuñez, Ana Isabel Heiniger Mazo, Katy Hurst, Manuel Barrios-Garcia, MJ Moreno, Antonio Jiménez-Velasco
Publikováno v:
Blood. 124:3653-3653
Philadelphia positive acute lymphoblastic leukemia (Ph + ALL) accounts for approximately 20% -30% of all adult ALL. The prognosis of patients with Phi + ALL is unfavorable when treated with standard chemotherapy schemes, presenting a long-term surviv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::04a95be1e9680065015c60f380dda209
https://doi.org/10.1182/blood.v124.21.3653.3653
https://doi.org/10.1182/blood.v124.21.3653.3653
Autor:
M.J. Ariza-Corbo, María Eva Mingot-Castellano, Ana Isabel Heiniger-Mazo, Álvaro Amo Vázquez de la Torre, Miguel Ángel Sánchez-Chaparro, María Inmaculada Alonso-Calderón, Pedro Valdivielso
Publikováno v:
ResearcherID
INTRODUCTION: Recent studies in male subjects with haemophilia have described a prevalence of cardiovascular risk factors (CVRF) and cardiovascular events (CVE) similar to the general population. This finding has not been tested in severe haemophilia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5afb1a374939954575a989575be4ef8f
https://doi.org/10.1182/blood.v124.21.5048.5048
https://doi.org/10.1182/blood.v124.21.5048.5048
Autor:
Rocio Tamayo-Bermejo, Laura González-Díaz, Maria Eva Mingot-Castellano, Ana Isabel Heiniger-Mazo
Publikováno v:
Blood. 124:5052-5052
Background: Prophylaxis is the treatment of choice in patients with severe hemophilia A to prevent the development of haemophilic arthropathy and to preserve musculoskeletal function. In adult patients, there is no defined consensus on the indication
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ce962e9e27a889112d013d4f1506f41
https://doi.org/10.1182/blood.v124.21.5052.5052
https://doi.org/10.1182/blood.v124.21.5052.5052
Autor:
Maria Cristina Moragues Martinez, Kati Hurst, Ana Isabel Heiniger Mazo, Maria Eva Mingot Castellano
Publikováno v:
Blood. 124:4196-4196
Introduction: Primary immune thrombocytopenia (ITP) is an acquired autoimmune disease characterized by accelerated platelet destruction and inadequate platelet production mediated by autoantibodies. As there are no specific diagnostic tests, the diag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de624035ca36e604a9d7bc31b9848f54
https://doi.org/10.1182/blood.v124.21.4196.4196
https://doi.org/10.1182/blood.v124.21.4196.4196
Autor:
Dana Diaz-Canales, Maria Rosario Prieto-Bonilla, Maria Eva Mingot-Castellano, Ana Isabel Heiniger Mazo
Publikováno v:
Blood. 122:1081-1081
Introduction Primary immune thrombocytopenia (ITP) is an acquired autoimmune disorder with a very variable outcome. Bleeding manifestations and platelets count are considered the main criteria to start treatment in these patients. The initial recomme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7df394827a04c5189c1d16cfa9941e4b
https://doi.org/10.1182/blood.v122.21.1081.1081
https://doi.org/10.1182/blood.v122.21.1081.1081